Analytical Data
-
基因名
RPL36AL
- Application
-
别名
RPL36AL; 60S ribosomal protein L36a-like; Large ribosomal subunit protein eL42-like
-
种属
Human
-
表达系统
E. coli
-
标签
N- GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q969Q0
-
表达区间
1-106aa
-
分子量
39.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RPL36AL, a member of the ribosomal protein family, is encoded by the RPL36AL gene located on chromosome 19. This protein plays a crucial role in the assembly and function of the ribosome, which is essential for protein synthesis in all living organisms. Recent studies have highlighted the importance of ribosomal proteins like RPL36AL in various cellular processes beyond their classical role in ribosome biogenesis. Alterations in RPL36AL expression have been associated with several diseases, particularly cancer, suggesting that it may contribute to tumorigenesis through its influence on cell growth, proliferation, and the modulation of the cellular stress response. Moreover, the potential involvement of RPL36AL in the regulation of mRNA translation makes it an intriguing target for further investigation, particularly in the context of the cancer microenvironment and therapeutic resistance. Understanding the precise role of RPL36AL and its regulatory mechanisms could provide insights into novel therapeutic strategies for cancer treatment and enhance our understanding of ribosomal protein contributions to cellular function and disease. This growing body of research underscores the significance of RPL36AL as a biomarker and therapeutic target, paving the way for future studies aimed at elucidating its role in health and disease.
